300458:SZSEAllwinner Technology Co., Ltd. Class A Analysis
Data as of 2026-06-14 - not real-time
CN¥30.34
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Allwinner Technology trades at CNY 30.34, barely above its technical support of CNY 30 and well below its 20‑day (34.54) and 50‑day (33.69) SMAs, indicating a price lagging broader averages. The MACD is in a bearish configuration and the RSI sits at 34.8, suggesting limited upside momentum, while volume is trending downwards and 30‑day volatility is high at nearly 49%. Fundamentally, revenue surged 47% YoY and margins remain respectable (gross 34.6%, operating 21%), yet the stock is markedly overvalued with a trailing PE of 79.8 versus an industry average of 36.8 and a DCF‑derived fair value of just CNY 11.36. Cash generation is strained – free cash flow is negative and the modest 0.66% dividend rests on a 41.8% payout ratio, raising concerns about sustainability.
Overall, the blend of weak technical signals, pronounced overvaluation, and cash‑flow pressure tempers enthusiasm, though the underlying growth narrative in the semiconductor sector offers a longer‑run upside if valuation compresses and cash generation improves.
Overall, the blend of weak technical signals, pronounced overvaluation, and cash‑flow pressure tempers enthusiasm, though the underlying growth narrative in the semiconductor sector offers a longer‑run upside if valuation compresses and cash generation improves.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and price below key moving averages
- Proximity to technical support at CNY 30
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong 47% revenue growth
- Significant overvaluation relative to peers
- Negative free cash flow limiting reinvestment
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Growth potential in semiconductor and IoT markets
- Current price far above DCF fair value
- Regulatory and geopolitical exposure in China
Key Metrics & Analysis
Financial Health
Revenue Growth47.10%
Profit Margin11.94%
P/E Ratio79.8
ROE11.65%
ROA5.48%
Debt/Equity2.77
P/B Ratio8.9
Op. Cash FlowCN¥382.1M
Free Cash FlowCN¥-84273096
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI34.8
SupportCN¥30.00
ResistanceCN¥39.88
MA 20CN¥34.54
MA 50CN¥33.69
MA 200CN¥35.84
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair ValueCN¥11.36
GradeOvervalued
TypeGrowth
Dividend Yield0.66%
Risk Assessment
Beta0.24
Volatility48.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.